|
|
|
Insider
Information: |
Raines Merilee |
Relationship: |
|
City: |
Westbrook |
State: |
ME |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
93,212 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$19,918,480 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
93,212 |
|
|
Total
Value |
$19,918,480 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Idexx Laboratories Inc |
IDXX |
Executive VP & CFO |
2013-02-25 |
26,577 |
2013-02-01 |
0 |
Premium* |
|
Watts Industries Inc |
WTS |
Director |
2023-07-31 |
20,020 |
2011-03-01 |
0 |
Premium* |
|
Affymetrix Inc |
AFFX |
Director |
2016-03-31 |
0 |
2015-05-13 |
0 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
Director |
2019-07-18 |
0 |
2016-06-24 |
0 |
Premium* |
|
Benchmark Electronics Inc |
BHE |
Director |
2021-05-12 |
24,489 |
2019-05-15 |
0 |
Premium* |
|
Ocular Therapeutix, Inc |
OCUL |
Director |
2023-06-14 |
20,933 |
2022-06-16 |
0 |
Premium* |
|
Transmedics Group, Inc. |
TMDX |
|
2023-05-25 |
1,193 |
2023-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
WTS |
Watts Industries Inc |
Director |
|
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,381 |
16,135 |
0 |
- |
|
BHE |
Benchmark Electronics Inc |
Director |
|
2020-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,883 |
19,289 |
0 |
- |
|
WTS |
Watts Industries Inc |
Director |
|
2020-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,359 |
17,494 |
0 |
- |
|
BHE |
Benchmark Electronics Inc |
Director |
|
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,200 |
24,489 |
0 |
- |
|
WTS |
Watts Industries Inc |
Director |
|
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
794 |
18,288 |
0 |
- |
|
OCUL |
Ocular Therapeutix, Inc |
Director |
|
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,933 |
8,933 |
0 |
- |
|
WTS |
Watts Industries Inc |
Director |
|
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,019 |
19,307 |
0 |
- |
|
TMDX |
Transmedics Group, Inc. |
|
|
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,193 |
1,193 |
0 |
- |
|
OCUL |
Ocular Therapeutix, Inc |
Director |
|
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
20,933 |
0 |
- |
|
WTS |
Watts Industries Inc |
Director |
|
2023-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
713 |
20,020 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Corporate Vice President & CFO |
|
2009-08-12 |
4 |
OE |
$8.84 |
$353,752 |
D/D |
40,000 |
165,502 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
|
2010-08-10 |
4 |
OE |
$11.34 |
$666,792 |
D/D |
56,000 |
201,481 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Corporate Vice President & CFO |
|
2008-08-22 |
4 |
OE |
$12.25 |
$490,000 |
D/D |
40,000 |
145,807 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
|
2011-08-12 |
4 |
OE |
$13.32 |
$319,560 |
D/D |
24,000 |
195,294 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Corporate Vice President & CFO |
|
2007-09-04 |
4 |
OE |
$13.69 |
$61,758 |
D/D |
4,512 |
46,289 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Corporate Vice President & CFO |
|
2007-09-05 |
4 |
OE |
$13.69 |
$211,992 |
D/D |
15,488 |
57,265 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Vice President,CFO & Treasurer |
|
2003-11-24 |
4 |
OE |
$14.38 |
$2,875 |
D/D |
200 |
11,200 |
|
- |
|
IDXX |
Idexx Laboratories Inc |
Vice President CFO & Treasurer |
|
2004-02-09 |
4 |
OE |
$15.00 |
$90,000 |
D/D |
6,000 |
13,700 |
|
- |
|
IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
|
2012-05-04 |
4 |
OE |
$17.14 |
$199,978 |
D/D |
8,444 |
179,465 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
|
2012-08-08 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
178,747 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
|
2012-09-12 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
178,747 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
|
2012-10-10 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
178,747 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
|
2012-11-14 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
153,747 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
|
2012-12-12 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
153,747 |
0 |
- |
|
IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
|
2013-01-09 |
4 |
OE |
$17.14 |
$175,463 |
D/D |
7,726 |
153,747 |
0 |
- |
|
93 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|